XML 33 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 100 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Mar. 31, 2014
Costs and Expenses:      
Research and development $ 13,299 $ 14,344 $ 121,636
Purchased in-process research and development     29,157
General and administrative 3,178 3,278 42,444
Loss from Operations (16,477) (17,622) (193,237)
Other Income/(Loss)      
Interest and investment income 58 18 613
Other income/(expense) (29)   1,301
Change in fair value of derivative instruments-warrants 223 (1,093) 3,993
Total Other Income/(loss) 252 (1,075) 5,907
Loss from Continuing Operations (16,225) (18,697) (187,330)
Loss from Discontinued Operations     (72)
Net Loss $ (16,225) $ (18,697) $ (187,402)
Weighted Average Common Shares Outstanding      
Basic and Diluted (in shares) 92,056,124 72,789,006  
Net Loss per Common Share, Basic and Diluted      
Net Loss per Common Share, Basic and Diluted (in dollars per share) $ (0.18) $ (0.26)